Statutory guidance

MHRA fees

Fees payable to the MHRA for 20222023 to 20232024

Documents

MHRA fees definitions

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Fees extracts

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Fees for new suppliers of defined simple active pharmaceutical ingredients (APIs)

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The document attached lists MHRA fees for 20222023 to 2023.2024. It incorporates new EU Exit fees which came into force on 1 January 2021.

For further information on EU Exit fees see The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020.

Published 18 December 2014
Last updated 81 MarchApril 2023 + show all updates
  1. Updated MHRA fees for 2023 - 2024

  2. Added link to application form to 'apply for Small and Medium Company status'.

  3. CURRENT FEES UPDATED

  4. Changes to MHRA fees for 2021 - 2022

  5. Published a new version of the 'Payment Easements and Waivers for Small and Medium Companies, as a HTML document. This replaces the 'Payment Easements for Small Companies' PDF.

  6. Update on the MHRA fees for Licence applications: marketing authorisations; Orphan Marketing Products: fees; Variations: licence variations application fees; Variations: licence variations applications groups fees; and Variations: Traditional Herbal Registration Scheme fees

  7. Added new information on fees following the end of the transition period. This includes new sections on orphan marketing products, Pharmacovigilance (PV) Safety Reviews, pre-assessment (rolling review) fees, PMF and Vaccine Antigen Master File certification.

  8. Amended text under 'Current MHRA fees' guidance. Section '13. Inspection: fees'.

  9. We have updated the years references to the periodic fees

  10. Update to confirm fee levels for 2020 to 2021 are remaining the same as 2019 to 2020

  11. Minor amendment to the explanation of the Office Based Inspection Fee to include information that was left out by mistake.

  12. Information about 2017/18 fees added to the page.

  13. MHRA's fees changed on April 1 2016.

  14. MHRA's fees change on April 1 2016. Uploaded a PDF of the changed fees.

  15. First published.